NewsTradingSentimentCalendarCommunityBriefing
Stocks LIVE

Clover Health Shares Rise on New Coverage Initiation

By Stocks Desk · 2026-09-10 · Updated 2026-09-11 04:19 UTC
A stethoscope resting on a desk next to a stack of medical files
Illustration: Tradingbird

Clover Health shares are trading higher following a new Buy initiation from Deutsche Bank, with the stock gapping up to nearly $4.70 on elevated volume. While analysts remain divided on the valuation, recent data highlights significant insider selling by top executives despite the positive technical momentum.

  • GN stocks/nasdaq reports that CLOV gapped up to open at $4.48 before trading as high as $4.695, with volume reaching 1.47 million shares. The article also notes recent insider sales by CEO Andrew Toy and VP Joseph Frank Oldakowski, both executed under 10b5-1 plans to cover tax obligations.

    Source: GN stocks/nasdaq
  • Clover Health stock climbed 8.5% following a Buy rating from Deutsche Bank, which highlighted the firm's Medicare Advantage growth potential and proprietary technology platform.

    Source: GN stocks/nasdaq
Based on reporting by GN stocks/nasdaq and GN stocks/nasdaq, compiled by the Tradingbird desk.

More from the Stocks desk

All desk stories